A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases

NCT00649207 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain Diseases
Brain Neoplasms
Central Nervous System Diseases
Neoplasm Metastasis
Nervous System Neoplasms

Interventions

DRUG: ABT-888
RADIATION: Whole Brain Radiation Therapy

Sponsor

AbbVie (prior sponsor, Abbott)